Mch3, an apoptotic protease, nucleic acids encoding and methods of use
CA 2237618 C · Owner: Fernandez-Alnemri, Teresa · Inventors: Tomaselli, Kevin; Litwack, Gerald; Alnemri, Emad S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides an isolated gene encoding Mch3 or functional fragment , thereof. Also provided is an isolated nucleic acid squence encoding Mch3 or functional fragment thereof. The gene or nucleic acid sequence can be single or double stranded nucleic acids corresponding to coding or non-coding strands of the Mch3 nucleotide sequence. An isolated Mch3 polypeptide or functional fragment thereof is also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 12, 1996 and granted April 19, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 12, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 12, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.